Diagnosis and management of transient ischaemic attacks in accident and emergency.

Stroke is an important cause of morbidity and mortality. Often the first presentation of cerebrovascular disease is a TIA which will present to the A&E department. Patients who have had a TIA are at increased risk of stroke, myocardial infarction, and vascular death. The risk of stroke after a TIA is greatest in the first year (approximately 11.6%) with a risk of approximately 5.9% per year over the first five years. As the risk is highest in the first months following a TIA it is important that the patients are diagnosed accurately, investigated promptly, and referred appropriately for treatment in order that valuable time is not lost. For this reason A&E physicians have a valuable role in the initial assessment and management of the patient. It has been advocated that patients should be seen by a neurologist or physician with an interest in cerebrovascular disease within days of their symptoms and be prepared for surgery within two weeks after a TIA. While it is usually not possible to achieve this ideal, improved cooperation between A&E physicians and these neurologists, general physicians, and geriatricians should lead to the implementation of speedy efficient referral procedures which can only improve patient care. When you next see a patient with a TIA in the A&E department remember what they have to lose. Three questions relating to this article are: (1) How are TIAs subdivided and what clinical features allow this differentation? (2) What are the initial investigations that should be performed in A&E? (3) When are the risks of completed stroke greatest after a TIA? Enumerate these risks. How effective is aspirin at reducting this risks?     

Transient ischemic attacks: clinical features, pathophysiology and management

A transient ischemic attack (TIA) is a symptom of underlying vascular disease that requires prompt, accurate diagnosis to prevent its possible complications of stroke, myocardial infarction or death. This article presents the clinical features, pathophysiology, clinical course and management of TIAs. Study of the pathophysiology includes a review of normal physiology of the cerebral vascular system, as well as age-related physiologic changes that put the elderly at increased risk for TIAs. The management plan presented includes reduction of risk factors, patient education, physician referral, and medical and/or surgical treatment. Controversies over medical and surgical treatment are briefly examined.     

Transient Ischemic Attacks (TIA): Current Issues in Diagnosis and Management

Transient ischemic attacks (TIAs) affect more than 500,000 Americans each year. Stroke risk approximates 4% to 8% within 1 month and increases to 12% to 13% at one year. This has led to stroke being one of the leading causes of death and disability. TIAs are focal neurologic events that are temporary in nature and warn of potential stroke. Most TIAs resolve within 24 hours. Hypertension, smoking, heart disease, and diabetes are the major risk factors for stroke. A comprehensive history of symptoms can help identify carotid vs. vertebrobasilar disease. Timely evaluation of TIAs should be performed according to recent guidelines set forth by the American Heart Association. Aspirin continues to be the gold standard for stroke prevention, conferring a 48% risk reduction in stroke or death. The use of ticlopidine has been recommended as a second-line agent in patients with aspirin intolerance. Surgical intervention (carotid endarterectomy) is indicated in symptomatic patients with high grade stenosis of 70% or greater. For patients with less significant stenosis, inconclusive data exists regarding the benefit of medical vs. surgical treatment. Patient education should address identification of symptoms, the need for prompt medical attention, and risk factor modification. A collaborative plan between clinician and client will facilitate early intervention ultimately leading to preservation of function and prevention of the catastrophic sequelae of stroke.     

THE CHANGING INDICATIONS FOR CAROTID ENDARTERECTOMY IN THE UK

In early series the majority of carotid endarterectomies were performed in patients with amaurosis fugax (AFx) or transient ischaemic attacks (TIAs) who were thought to have atheromatous ulcers of the carotid bifurcation or the internal carotid artery (ICA). The degree of stenosis was considered to be of secondary importance. We compared our own data with two British series undertaken in the early and late 80s/early 90s. This reflects the broadening of indications and the change of practice for carotid endarterectomy over the years, on the one hand towards including patients who are at greater risk of perioperative stroke (previous CVAs vs TIAs, crescendo TIAs and stroke in evolution), and on the other towards patients who have had no symptoms attributable to the carotid lesion (asymptomatic cases, combined carotid and cardiac procedures).     

Carotid endarterectomy for stroke prevention

Minor neurologic signs or transient ischemic attacks (TIAs) precede stroke in 50 percent of patients. In men, antiplatelet therapy decreases the risk of recurrent TIA and stroke. Carotid endarterectomy for TIA is now one of the most commonly performed vascular operations. Preoperatively, the arterial anatomy of the patient must be carefully studied by conventional angiography or digital subtraction angiography. The goal of surgery is to eliminate the atherosclerotic plaque and restore the artery to its normal size with a smooth intima.     

Carotid endarterectomy. Controversies and recommendations

Carotid endarterectomy is a comparatively safe procedure for prevention of stroke in carefully selected patients with carotid stenosis. Generally, it is indicated in patients with hemispheric symptoms of transient ischemic attacks (TIAs), but it is more controversial in patients with non-hemispheric TIA symptoms or no symptoms. Emergency endarterectomy in patients with acute TIA symptoms is considered dangerous. Results of a series of 120 endarterectomies performed at Straub Clinic, Honolulu, confirm the benefits of elective endarterectomy when a meticulous operative technique is followed and intraoperative angiography and repair of defects are done. Prophylactic endarterectomy should not be performed unless a very low incidence (less than or equal to 3%) of combined major morbidity and mortality can be achieved.     

Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale

As many as 300,000 transient ischemic attacks (TIAs) occur in the United States each year, accounting for 0.3% of all Emergency Department visits. An under-recognized and under-treated problem, TIA is associated with up to a 10% risk of subsequent stroke within 7 days and a 25% risk of death at 1 year. Antiplatelet therapy can result in significant reductions in secondary stroke risk. However, nearly 50% of patients with TIA leave the Emergency Department without any medication. This article discusses recent results from major antiplatelet clinical trials in stroke prevention and highlights the need for appropriate and timely initiation of antiplatelet treatment in patients with TIA.     

THE MEDICAL MANAGEMENT OF STROKE

The management of stroke, so long a ‘Cinderella’ condition, is changing rapidly as new developments appear for acute treatment, rehabilitation and secondary prevention. Most patients with acute stroke now need rapid assessment at hospital following the onset of symptoms. Those needing admission should be managed on an acute stroke unit for stabilisation, CT scanning and other investigation, and diagnosis, and then referred, as appropriate, to a specialist stroke rehabilitation unit. Aspirin is now the recognised treatment for acute ischaemic stroke (once primary Intracerebral haemorrhage has been excluded), and can be continued for secondary prevention. Attention should be paid to risk factors to prevent recurrence, especially treatment of hypertension, atrial fibrillation, and severe ipsilateral carotid stenosis. Patients with mild cerebrovascular disease should be managed in a specialist stroke/TIA clinic. Stroke is no longer an untreatable or unpreventable condition, and It is vital that hospitals design appropriate systems to manage patients in an interdisciplinary environment.     

Transient ischemic attacks.

The treatment of TIA must be individualized. TIA is one of several manifestations of generalized atherosclerosis. While one-third of patients with TIA will suffer a stroke in five years, one-half of the same group will die of myocardial infarction. The risk of stroke is greater in carotid rather than vertebral-basilar TIA, in older patients, and in those with a cluster of TIAS, an is highest in the first month after the TIA. Treatment should reflect this knowledge.     

Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge

BACKGROUND: Oral anticoagulation is indicated in secondary prevention of stroke or transient ischemic attack (TIA) in patients with atrial fibrillation, but it is often withheld because of contraindications and/or fear of bleeding complications. METHODS: We analysed recurrent cerebral and non-cerebral ischemic vascular events, major intracerebral and extracerebral bleeding and vascular death in 401 consecutive patients with ischemic stroke or TIA and atrial fibrillation who were discharged with oral anticoagulation (OAC), antiplatelet agents (AA), or heparin only in a clinical routine setting. The median follow-up time was 25 (interquartile range (IQR): 15-38) months. RESULTS: Patients on OAC at time of discharge were significantly younger and had suffered a major stroke less often than patients who received AA or heparin at discharge. One year after discharge, adherence to therapy was higher in patients discharged on OAC (72%) than in those on AA (46%; p<0.001). The majority of patients discharged on heparin were subsequently treated with OAC. Patients on AA at discharge suffered from ischemic complications significantly more often during the follow-up period than patients on OAC or heparin at discharge (30% vs. 16% vs. 23%, p=0.031). 3% of the patients on AA and 4% of those on OAC suffered from major bleeding complications during follow-up (p=0.028). CONCLUSION: Our results document the high risk of ischemic vascular complications in patients with ischemic stroke/TIA and atrial fibrillation in a clinical routine setting. The risk was particularly high in patients treated with AA. The risk of major bleeding complications in our population was comparably low.     

Transient ischemic attacks: Pathophysiology and medical management.

There is substantial evidence to support the concept that most transient ischemic attacks (TIAs) are caused by microemboli that originate in areas of atherosclerosis in the blood vessels of the neck. TIA's are important risk factors in the development of stroke. The most common clinical features of TIAs caused by carotid insufficiency are hemianesthesia and hemiparesis; other symptoms in these cases include headache, dysphasia, and visual field distrubance. By far the most common clinical manifestation of vertebrobasilar insufficiency is vertigo.     

The frequency of symptoms in transient ischaemic attack: analysis of Nanjing Stroke Register Program data

The clinical characteristics of 172 patients experiencing single or multiple (two or more) transient ischaemic attacks (TIAs) were investigated. Risk factors, clinical manifestations and vascular examinations were compared. Intracranial and extra-cranial large-artery disease (stenosis > or = 50%) occurred more frequently in multiple-TIA patients than in single-TIA patients, and weakness and atrial fibrillation were observed more frequently in single TIA than in multiple TIA patients. The type of aetiological examination performed in TIA patients should depend on the frequency of attacks.     

颈动脉狭窄性短暂性脑缺血发作的影像学研究

短暂性脑缺血发作是指突然发生的神经症状和体症,24h内恢复正常。以往主要依据临床表现诊断。随着影像学技术的发展应用,发现大多数TIA患者有脑血流动力学异常改变,脑血流动力学异常的持续存在,提示有必要对TIA的本质重新加以认识,对进行及时、准确治疗TIA,改善预后具有重要意义。本文对短暂性脑缺血发作的临床诊断依据、临床表现及其与颈动脉狭窄的关系以及影像学诊断方法等方面进行综述。     

TIA早期转化为脑梗死的血管因素分析

目的探讨颅内血管狭窄与短暂性脑缺血发作（transient ischemic attack,TIA）1周内转化为脑梗死的关系。方法临床收集121例TIA患者,观察患者住院1周内转化为脑梗死的百分率。查颅脑磁共振弥散加权成像（DWI）判断患者有无新鲜脑梗死,采用头颈CT血管造影（CTA）方法,检查所有患者颅内血管狭窄程度,分析颅内血管狭窄程度、部位、数量与TIA进展为脑梗死的关系。结果 121例TIA患者中,35例在发病1周内发生脑梗死（28.9%进展为脑梗死）。79例患者存在颅内血管狭窄,其中轻度狭窄36例、中度狭窄29例、重度狭窄14例。TIA后脑梗死的发生率与颅内动脉狭窄程度呈正相关（P〈0.01）,与颅内动脉责任血管狭窄、近端血管狭窄显著相关（P〈0.01）,多发脑血管狭窄导致TIA早期脑梗死的发生率明显升高（P〈0.01）。结论颅内血管狭窄是TIA早期转化为脑梗死的独立危险因素,颅内血管检查有助于TIA患者早期转化为脑梗死的风险评估。     

Transoesophageal echocardiography should be considered in patients with ischaemic stroke or transient ischaemic attack

BACKGROUND AND PURPOSE: In this present study, we tried to find out if there is a subgroup of patients that should not undergo transoesophageal echocardiography (TEE) after an ischaemic stroke or transient ischaemic attack (TIA). METHODS: A total of 441 consecutive unselected patients with ischaemic stroke or TIA suitable for anticoagulation were examined with TEE in the acute phase. The patients were divided into five subcategories according to their rhythm, age and the findings in carotid sonography, and into two groups according to the presence of clinical risk factors for ischaemic stroke or TIA. RESULTS: From the 441 studied patients, 60 (14%) had chronic or paroxysmal atrial fibrillation (AF) and 381 (86%) were in sinus rhythm (SR). Of the patients in SR, 46 (12%) were below 50 years old. The carotid sonography was conducted in 240 patients above 50 years old and in SR, and <50% internal carotid artery (ICA) stenosis was found in 194 (81%) patients and > or =50% ICA in 46 (19%) patients. Potential cardiac sources of embolism were found in patients both with AF or in SR (70% versus 46%), both below and above 50-year-old patients in SR (37% versus 47%), both in over 50-year-old patients in SR with <50% ICA stenosis and > or =50% ICA stenosis (41% versus 61%) and in patients in SR either without or with clinical risk factors for ischaemic stroke or TIA (43% versus 51%). On the basis of the TEE study, oral anticoagulation was started in 36 (9%) patients in SR. CONCLUSION: These results support TEE in patients with ischaemic stroke or TIA who are candidates for receiving oral anticoagulation.     

Carotid and vertebral-basilar transient cerebral ischemic attacks. A community study, Rochester, Minnesota

THE purpose of this study was to determine the difference in prognosis among patients with transient ischemic attacks (TIA) in the carotid arterial system and those with TIA in the vertebral-basilar arterial system. Nearly twice as many patients had TIA in the carotid system as had TIA in the vertebral-basilar system. The survival rates for patients with carotid TIA and those with vertebral-basilar TIA were similar. In both groups, the survival rate was lower than the expected survival rate, but only for the patients with carotid TIA was the difference significant. There was no significant difference in the probability of the occurrence of stroke between patients with carotid TIA and those with vertebral-basilar TIA. These data also indicate that the risk of stroke is much greater soon after the onset of TIA in either arterial system. Among all patients with TIA, the primary cause of death was cardiac disease. The causes of death had a similar distribution for patients with carotid TIA, for those with vertebral-basilar TIA, and for those with "mixed" or "unknown" types of TIA.     

Secondary prevention of stroke and transient ischaemic attack

Transient ischaemic attack (TIA) and stroke are clinical syndromes characterised by acute neurological deficits with vascular causes. People experiencing TIA or a first stroke are at significant risk of subsequent stroke. Risk factors have been identified and include factors associated with lifestyle such as tobacco use, diet, obesity, alcohol consumption, physical activity and stress. Targeted therapeutic interventions have the potential to reduce the burden of stroke substantially. The aim of this article is to provide an overview of the evidence relating to lifestyle risk factors for stroke. Health promotion theories and intervention techniques that nurses can use to address lifestyle behaviour change following stroke will also be discussed.     

Contrast-Enhanced Ultrasound to Assess Carotid Intraplaque Neovascularization

Contrast-enhanced ultrasound (CEUS) is increasingly being used to identify patients with carotid plaques that are vulnerable to rupture, so-called vulnerable atherosclerotic plaques, by assessment of intraplaque neovascularization. A complete overview of the strengths and limitations of carotid CEUS is currently not available. The aim of this systematic review was to provide a complete overview of existing publications on the role of CEUS in assessment of carotid intraplaque neovascularization. The systematic review of the literature yielded 52 studies including a total of 4660 patients (mean age: 66 y, 71% male) who underwent CEUS for the assessment of intraplaque neovascularization. The majority of the patients (76%) were asymptomatic and had no history of transient ischemic attack (TIA) or stroke. The assessment of intraplaque neovascularization was mostly performed using a visual scoring system; several studies used time–intensity curves or dedicated quantification software to optimize analysis. In 17 studies CEUS was performed in patients before carotid surgery (endarterectomy), allowing a comparison of pre-operative CEUS findings with histologic analysis of the tissue sample that is removed from the carotid artery. In a total of 576 patients, the CEUS findings were compared with histopathological analysis of the plaque after surgery. In 16 of the 17 studies, contrast enhancement was found to correlate with the presence and degree of intraplaque neovascularization on histology. Plaques with a larger amount of contrast enhancement had significantly increased density of microvessels in the corresponding region on histology. In conclusion, CEUS is a readily available imaging modality for the assessment of patients with carotid atherosclerosis, providing information on atherosclerotic plaques, such as ulceration and intraplaque neovascularization, which may be clinically relevant. The ultimate clinical goal is the early identification of carotid atherosclerosis to start early preventive therapy and prevent clinical complications such as TIA and stroke.     

Carotid sonography and transesophageal echocardiography in patients with ischemic stroke or transient ischemic attack in the territory of the carotid artery

PURPOSE: To assess the benefit of combining carotid sonography and transesophageal echocardiography (TEE) for the evaluation of patients with stroke or transient ischemic attack (TIA) in the territory of the carotid artery. METHODS: During a 2-year period in Turku University Hospital, consecutive in patients with stroke or TIA who were candidates for carotid endarterectomy and for oral anticoagulation were evaluated with carotid sonography for symptomatic moderate (50-69%) or severe (>or=70%) internal carotid artery (ICA) stenosis, and with TEE for potential cardiac sources of embolism. RESULTS: In 20% (40/197) of patients, a severe symptomatic ICA stenosis and/or a major risk factor for a cardiac source of embolism were found. In 56% (110/197) of patients, a moderate or severe symptomatic ICA stenosis and/or a potential cardiac source of embolism were found, whereas 11% (21/197) of patients had both a moderate or severe symptomatic ICA stenosis and a potential cardiac source of embolism. CONCLUSIONS: This study suggests that the presence of a moderate or severe symptomatic ICA stenosis does not exclude the presence of a potential cardiac source of embolism and vice versa. Carotid sonography and TEE complement each other and are valuable diagnostic tools that should be recommended in patients with ischemic stroke or TIA in the territory of the carotid artery when they are candidates for carotid endarterectomy and for oral anticoagulation.